Abstract
The Cre/lox site-specific recombination system allows the control of gene activity in space and time in almost any tissue of the mouse. A major technical advance was the development of tamoxifen-dependent Cre recombinases, such as CreERT2, that can be activated by administration of tamoxifen to the animal. This powerful tool greatly facilitates the study of gene functions and the generation of more realistic animal models of sporadic human diseases. Another important application of tamoxifen-dependent Cre recombinases is genetic inducible fate mapping (GIFM). In GIFM studies, the inducible Cre/lox system is used to genetically label a defined cell population at a selected time by irreversible activation of the expression of a Cre-responsive reporter transgene. Then, marked cells are detected at later time points to determine how the originally labeled progenitors contribute to specific structures and cell types during pre- and postnatal development. GIFM was initially applied during mouse embryogenesis, but is now increasingly used for cell lineage tracing in adult mice under physiological and pathophysiological conditions. Here we describe the design of GIFM experiments in adult mice as exemplified by CreERT2-assisted tracing of vascular smooth muscle cells during the development of atherosclerotic lesions. First, we give an overview of reporter transgenes available for genetic cell marking that are expressed from the Rosa26 locus, such as β-galactosidase and fluorescent proteins. Then we present detailed protocols for the generation of experimental mice for GIFM studies, the induction of cell labeling by tamoxifen treatment, and the detection of marked cells in fixed and live tissues. Each section also provides a discussion of limitations and common pitfalls of GIFM experiments. Most of the protocols can be easily adapted to other developmental stages, cell types, Cre recombinases, and reporter transgenes and, thus, can be used as general guidelines for GIFM studies in mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feil R (2007) Conditional somatic mutagenesis in the mouse using site-specific recombinases. Handb Exp Pharmacol 178:3–28
Glaser S, Anastassiadis K, Stewart AF (2005) Current issues in mouse genome engineering. Nat Genet 37(11):1187–1193
Garcia-Otin AL, Guillou F (2006) Mammalian genome targeting using site-specific recombinases. Front Biosci 11:1108–1136
Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21(1):70–71
Feil R, Brocard J, Mascrez B et al (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93(20):10887–10890
Feil R, Wagner J, Metzger D et al (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237(3):752–757
Metzger D, Clifford J, Chiba H et al (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A 92(15):6991–6995
Zhang Y, Riesterer C, Ayrall AM et al (1996) Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24(4):543–548
Indra AK, Warot X, Brocard J et al (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27(22):4324–4327
Kühbandner S, Brummer S, Metzger D et al (2000) Temporally controlled somatic mutagenesis in smooth muscle. Genesis 28(1):15–22
Robinson SP, Langan-Fahey SM, Johnson DA et al (1991) Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19(1):36–43
Furr BJ, Jordan VC (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25(2):127–205
Birling MC, Gofflot F, Warot X (2009) Site-specific recombinases for manipulation of the mouse genome. Methods Mol Biol 561:245–263
Feil S, Valtcheva N, Feil R (2009) Inducible Cre mice. Methods Mol Biol 530:343–363
Friedel RH, Wurst W, Wefers B et al (2011) Generating conditional knockout mice. Methods Mol Biol 693:205–231
O’Gorman S, Fox DT, Wahl GM (1991) Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251(4999):1351–1355
Lewandoski M (2007) Analysis of mouse development with conditional mutagenesis. Handb Exp Pharmacol 178:235–262
Dymecki SM, Tomasiewicz H (1998) Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev Biol 201(1):57–65
Zinyk DL, Mercer EH, Harris E et al (1998) Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr Biol 8(11):665–668
Dymecki SM, Kim JC (2007) Molecular neuroanatomy’s “three Gs”: a primer. Neuron 54(1):17–34
Joyner AL, Zervas M (2006) Genetic inducible fate mapping in mouse: establishing genetic lineages and defining genetic neuroanatomy in the nervous system. Dev Dyn 235(9):2376–2385
Ahn S, Joyner AL (2004) Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning. Cell 118(4):505–516
Harfe BD, Scherz PJ, Nissim S et al (2004) Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell 118(4):517–528
Gothert JR, Gustin SE, van Eekelen JA et al (2004) Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104(6):1769–1777
Laugwitz KL, Moretti A, Lam J et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026):647–653
Snippert HJ, Clevers H (2011) Tracking adult stem cells. EMBO Rep 12(2):113–122
Feil S, Hofmann F, Feil R (2004) SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res 94(7):863–865
Wolfsgruber W, Feil S, Brummer S et al (2003) A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells. Proc Natl Acad Sci U S A 100(23):13519–13524
Brown A, Brown S, Ellisor D et al (2009) A practical approach to genetic inducible fate mapping: a visual guide to mark and track cells in vivo. J Vis Exp 34. doi:10.3791/1687
Petersson M, Frances D, Niemann C (2013) Lineage tracing of hair follicle stem cells in epidermal whole mounts. Methods Mol Biol 989:45–60
Friedrich G, Soriano P (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5(9):1513–1523
Zambrowicz BP, Imamoto A, Fiering S et al (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A 94(8):3789–3794
Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108(2):193–199
Chen CM, Krohn J, Bhattacharya S et al (2011) A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 6(8):e23376
Nyabi O, Naessens M, Haigh K et al (2009) Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells. Nucleic Acids Res 37(7):e55
Muzumdar MD, Tasic B, Miyamichi K et al (2007) A global double-fluorescent Cre reporter mouse. Genesis 45(9):593–605
Madisen L, Zwingman TA, Sunkin SM et al (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13(1):133–140
Snippert HJ, van der Flier LG, Sato T et al (2010) Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143(1):134–144
Duffield JS, Humphreys BD (2011) Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 79(5):494–501
Zhang SH, Reddick RL, Piedrahita JA et al (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258(5081):468–471
Lakso M, Pichel JG, Gorman JR et al (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A 93(12):5860–5865
Kawamoto S, Niwa H, Tashiro F et al (2000) A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett 470(3):263–268
Erdmann G, Schutz G, Berger S (2007) Inducible gene inactivation in neurons of the adult mouse forebrain. BMC Neurosci 8:63
Lu X, Agasti SS, Vinegoni C et al (2012) Optochemogenetics (OCG) allows more precise control of genetic engineering in mice with CreER regulators. Bioconjug Chem 23(9):1945–1951
Brake RL, Simmons PJ, Begley CG (2004) Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice. Genet Mol Res 3(4):456–462
Wong MH, Saam JR, Stappenbeck TS et al (2000) Genetic mosaic analysis based on Cre recombinase and navigated laser capture microdissection. Proc Natl Acad Sci U S A 97(23):12601–12606
Mao X, Fujiwara Y, Chapdelaine A et al (2001) Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97(1):324–326
Srinivas S, Watanabe T, Lin CS et al (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4
Yamamoto M, Shook NA, Kanisicak O et al (2009) A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. Genesis 47(2):107–114
Acknowledgments
We thank the members of the Feil laboratory for critical discussion. Work in the authors’ laboratory was supported by grants from VolkswagenStiftung, Deutsche Forschungsgemeinschaft, fortüne-Programm der Medizinischen Fakultät der Universität Tübingen, and Dr. Karl Kuhn-Stiftung.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Feil, S., Krauss, J., Thunemann, M., Feil, R. (2014). Genetic Inducible Fate Mapping in Adult Mice Using Tamoxifen-Dependent Cre Recombinases. In: Singh, S., Coppola, V. (eds) Mouse Genetics. Methods in Molecular Biology, vol 1194. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1215-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1215-5_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1214-8
Online ISBN: 978-1-4939-1215-5
eBook Packages: Springer Protocols